Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2009 | 06-2008 | 06-2007 | 06-2006 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 0 | -1,410 | 0 | -5,740 |
| Depreciation Amortization | N/A | 0 | 1,450 | 0 | 1,130 |
| Other Working Capital | N/A | 0 | 780 | 0 | -300 |
| Other Operating Activity | 0 | 370 | 1,040 | -5,950 | -100 |
| Operating Cash Flow | $N/A | $370 | $1,860 | $-5,950 | $-5,010 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -40 | -130 | -150 | -10 |
| Other Investing Activity | 0 | 0 | 270 | 0 | 0 |
| Investing Cash Flow | $N/A | $-40 | $140 | $-150 | $-10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | -700 | -390 | -450 | 10,060 |
| Financing Cash Flow | $N/A | $-700 | $-390 | $-450 | $10,060 |
| Exchange Rate Effect | N/A | 0 | 1,050 | 30 | 530 |
| Beginning Cash Position | N/A | 12,350 | 7,900 | 18,410 | 7,890 |
| End Cash Position | N/A | 11,980 | 10,560 | 11,880 | 13,460 |
| Net Cash Flow | $N/A | $-370 | $2,660 | $-6,520 | $5,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 370 | 1,860 | -5,950 | -5,010 |
| Free Cash Flow | 0 | 370 | 1,860 | -5,950 | -5,010 |